APA (7th ed.) Citation

Koeth, R., Levison, B., Culley, M., Buffa, J., Wang, Z., Gregory, J., . . . Hazen, S. (2014). γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO. Cell metabolism, 20(5), 799-812. https://doi.org/10.1016/j.cmet.2014.10.006

Chicago Style (17th ed.) Citation

Koeth, Robert A, et al. "γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO." Cell Metabolism 20, no. 5 (2014): 799-812. https://doi.org/10.1016/j.cmet.2014.10.006.

MLA (9th ed.) Citation

Koeth, Robert A, et al. "γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO." Cell Metabolism, vol. 20, no. 5, 2014, pp. 799-812, https://doi.org/10.1016/j.cmet.2014.10.006.